Animal-based collagen represents 65.0% within the source type segment and B2B ingredient supply accounts for 57.0% of the sales channel category in 2026. The collagen hydrolysates market is estimated at USD 1.4 billion in 2026 and is forecast to post a 7.8% CAGR between 2026 and 2036.